INTERNATIONAL PATENT: ZHEJIANG UNIVERSITY INNOVATION INSTITUTE FOR ARTIFICIAL INTELLIGENCE IN MEDICINE, 浙江大学智能创新药物研究院 FILES APPLICATION FOR "TUMOR DUAL-TARGETING T CELL ENGAGER TARGETING EGFR AND HER2 AND USE THEREOF"

GENEVA, Sept. 28 -- ZHEJIANG UNIVERSITY INNOVATION INSTITUTE FOR ARTIFICIAL INTELLIGENCE IN MEDICINE (Building 6, Heda Pharmaceutical Valley Center, No. 291 Fucheng Road, Xiasha Subdistrict, Qiantang DistrictHangzhou, Zhejiang 310058), 浙江大学智能创新药物研究院 (中国浙江省杭州市钱塘区下沙街道福城路291号和达药谷中心6幢) filed a patent application (PCT/CN2025/083701) for "TUMOR DUAL-TARGETING T CELL ENGAGER TARGETING EGFR AND HER2, AND USE THEREOF" on Mar 20, 2025. With publication no. WO/2025/195450, the detail...